DRREDDY.NS Profit & Loss
Dr. Reddy's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹14,281.00 Cr. | ₹15,448.20 Cr. | ₹17,517.00 Cr. | ₹19,047.50 Cr. | ₹21,545.20 Cr. | ₹24,669.70 Cr. | ₹28,011.10 Cr. | ₹32,643.90 Cr. | ₹33,700.20 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹14,281.00 Cr. | ₹15,448.20 Cr. | ₹17,517.00 Cr. | ₹19,047.50 Cr. | ₹21,545.20 Cr. | ₹24,669.70 Cr. | ₹28,011.10 Cr. | ₹32,643.90 Cr. | ₹33,700.20 Cr. | SegmentRevenueFromOperations |
| Other Income | ₹155.20 Cr. | ₹337.50 Cr. | ₹620.60 Cr. | ₹291.40 Cr. | ₹484.40 Cr. | ₹1,055.50 Cr. | ₹894.30 Cr. | ₹1,097.30 Cr. | ₹1,358.40 Cr. | OtherIncome |
| Total Income | ₹14,436.20 Cr. | ₹15,785.70 Cr. | ₹18,137.60 Cr. | ₹19,338.90 Cr. | ₹22,029.60 Cr. | ₹25,725.20 Cr. | ₹28,905.40 Cr. | ₹33,741.20 Cr. | ₹35,058.60 Cr. | Income |
| Cost of Materials Consumed | ₹2,630.90 Cr. | ₹2,889.40 Cr. | ₹2,984.80 Cr. | ₹4,295.80 Cr. | ₹4,312.40 Cr. | ₹4,219.80 Cr. | ₹4,490.10 Cr. | ₹5,683.50 Cr. | ₹6,501.20 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹1,450.10 Cr. | ₹1,880.80 Cr. | ₹2,545.90 Cr. | ₹2,573.60 Cr. | ₹3,483.70 Cr. | ₹3,367.00 Cr. | ₹4,399.10 Cr. | ₹4,841.10 Cr. | ₹6,161.60 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-41.50 Cr. | ₹-275.40 Cr. | ₹23.70 Cr. | ₹-790.50 Cr. | ₹-353.90 Cr. | ₹70.90 Cr. | ₹-680.50 Cr. | ₹-544.70 Cr. | ₹-423.60 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹3,214.90 Cr. | ₹3,356.20 Cr. | ₹3,380.20 Cr. | ₹3,629.90 Cr. | ₹3,885.80 Cr. | ₹4,646.60 Cr. | ₹5,030.10 Cr. | ₹5,580.00 Cr. | ₹5,990.90 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹78.80 Cr. | ₹88.90 Cr. | ₹98.30 Cr. | ₹97.00 Cr. | ₹95.80 Cr. | ₹142.80 Cr. | ₹171.10 Cr. | ₹282.90 Cr. | ₹373.80 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹1,077.20 Cr. | ₹1,134.80 Cr. | ₹1,163.10 Cr. | ₹1,228.80 Cr. | ₹1,165.20 Cr. | ₹1,250.20 Cr. | ₹1,470.00 Cr. | ₹1,703.70 Cr. | ₹2,058.80 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹4,675.40 Cr. | ₹4,419.00 Cr. | ₹6,112.00 Cr. | ₹5,468.80 Cr. | ₹6,449.50 Cr. | ₹6,016.40 Cr. | ₹6,839.20 Cr. | ₹8,536.90 Cr. | ₹9,016.60 Cr. | OtherExpenses |
| Total Expenses | ₹13,085.80 Cr. | ₹13,493.70 Cr. | ₹16,308.00 Cr. | ₹16,503.40 Cr. | ₹19,038.50 Cr. | ₹19,713.70 Cr. | ₹21,719.10 Cr. | ₹26,083.40 Cr. | ₹29,679.30 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹1,350.40 Cr. | ₹2,292.00 Cr. | ₹1,829.60 Cr. | ₹2,835.50 Cr. | ₹2,991.10 Cr. | ₹6,011.50 Cr. | ₹7,186.30 Cr. | ₹7,657.80 Cr. | ₹5,379.30 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1,350.40 Cr. | ₹2,292.00 Cr. | ₹1,829.60 Cr. | ₹2,835.50 Cr. | ₹2,991.10 Cr. | ₹6,011.50 Cr. | ₹7,186.30 Cr. | ₹7,657.80 Cr. | ₹5,379.30 Cr. | ProfitBeforeTax |
| Tax Expense | ₹438.00 Cr. | ₹385.80 Cr. | ₹-140.30 Cr. | ₹931.90 Cr. | ₹878.90 Cr. | ₹1,541.20 Cr. | ₹1,623.10 Cr. | ₹1,954.30 Cr. | ₹1,235.10 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹946.80 Cr. | ₹1,950.00 Cr. | ₹2,026.00 Cr. | ₹1,951.60 Cr. | ₹2,182.50 Cr. | ₹4,507.30 Cr. | ₹5,577.90 Cr. | ₹5,725.20 Cr. | ₹4,157.60 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹946.80 Cr. | ₹1,950.00 Cr. | ₹2,026.00 Cr. | N/A | N/A | N/A | ₹0.00 Cr. | ₹5,655.10 Cr. | ₹4,196.00 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹57.08 | ₹117.53 | ₹122.22 | ₹117.67 | ₹131.57 | ₹271.47 | ₹335.22 | ₹67.89 | ₹50.41 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹56.96 | ₹117.33 | ₹121.99 | ₹117.34 | ₹131.21 | ₹270.90 | ₹334.59 | ₹67.79 | ₹50.35 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from DRREDDY.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).